Investigations and Compliance

  • Conducted dozens of internal investigations of potential liability under the US Foreign Corrupt Practices Act (FCPA) and local anticorruption rules, including recent investigations of:
    • clinical trials in China by a pharmaceutical company
    • recruiting practices in China of a financial institution
    • marketing practices in Indonesia of a technology company
    • customs clearance and sales practices of a technology company in Singapore, Indonesia, and China
    • use of consultants in Indonesia, Malaysia, and China by financial institutions
  • Represented audit committees of multiple China-based issuers in internal investigations of allegations of fraud and accounting irregularities
  • Represented individual defendants in internal investigations and government investigations of collusion in fixing of reference foreign exchange rates and other regulated market misconduct

Antitrust and Competition

  • Advised US manufacturing company on merger clearance in China and other jurisdictions in USD 5 billion dollar acquisition of competitor
  • Advised major technology company in investigation of competitor's IP licensing practices by Chinese authorities
  • Advised Asian manufacturer in investigation of price-fixing by employees and disclosure to competition authorities
  • Advised hard-drive manufacturer in obtaining conditional clearance of acquisition of competitor in China and other jurisdictions
  • Advised US entertainment company on antitrust and other regulatory issues regarding strategic joint venture with Chinese entertainment company